Prospective, randomized comparison of high-dose chemotherapy with stem-cell support versus intermediate-dose chemotherapy after surgery and adjuvant chemotherapy in women with high-risk primary breast cancer: a report of CALGB 9082, SWOG 9114, and NCIC MA-13.

Prospective, randomized comparison of high-dose chemotherapy with stem-cell support versus intermediate-dose chemotherapy after surgery and adjuvant chemotherapy in women with high-risk primary breast cancer: a report of CALGB 9082, SWOG 9114, and NCIC MA-13. J Clin Oncol. 2005 Apr 01; 23(10):2191-200.

View in: PubMed

subject areas

Adult
Aged
Antineoplastic Combined Chemotherapy Protocols
Breast Neoplasms
Carmustine
Chemotherapy, Adjuvant
Cisplatin
Cyclophosphamide
Disease-Free Survival
Dose-Response Relationship, Drug
Female
Granulocyte Colony-Stimulating Factor
Humans
Lymphatic Metastasis
Middle Aged
Neoplasm Staging
Peripheral Blood Stem Cell Transplantation
Prognosis
Prospective Studies
Risk Factors
Treatment Outcome

authors with profiles

Richard Schilsky